Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q411917> ?p ?o }
Showing triples 1 to 73 of
73
with 100 triples per page.
- Q411917 subject Q8343807.
- Q411917 subject Q8614491.
- Q411917 subject Q8647962.
- Q411917 subject Q8808791.
- Q411917 subject Q8844484.
- Q411917 abstract "Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has no to few central effects. A synthetic quaternary amine, it is available in oral and intravenous (i.v.) forms. It was developed by Sosei and licensed to Novartis in 2005. The cation, which is the active moiety, is also known as glycopyrrolate.".
- Q411917 atcPrefix "A03".
- Q411917 atcSuffix "AB02".
- Q411917 casNumber "596-51-0".
- Q411917 drugbank "DB00986".
- Q411917 fdaUniiCode "V92SO9WP2I".
- Q411917 iupacName "3-(2-Cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidinium".
- Q411917 iupacName "3-[2-Cyclopentyl(hydroxy)phenylacetoxy]-1,1-dimethylpyrrolidinium bromide".
- Q411917 pubchem "11693".
- Q411917 pubchem "3494".
- Q411917 thumbnail Glycopyrronium_bromide.svg?width=300.
- Q411917 wikiPageWikiLink Q1029907.
- Q411917 wikiPageWikiLink Q1077823.
- Q411917 wikiPageWikiLink Q11158.
- Q411917 wikiPageWikiLink Q113259.
- Q411917 wikiPageWikiLink Q12140.
- Q411917 wikiPageWikiLink Q131130.
- Q411917 wikiPageWikiLink Q13400765.
- Q411917 wikiPageWikiLink Q155925.
- Q411917 wikiPageWikiLink Q156.
- Q411917 wikiPageWikiLink Q167198.
- Q411917 wikiPageWikiLink Q172941.
- Q411917 wikiPageWikiLink Q174778.
- Q411917 wikiPageWikiLink Q178436.
- Q411917 wikiPageWikiLink Q199804.
- Q411917 wikiPageWikiLink Q217111.
- Q411917 wikiPageWikiLink Q221694.
- Q411917 wikiPageWikiLink Q23005640.
- Q411917 wikiPageWikiLink Q245359.
- Q411917 wikiPageWikiLink Q3286619.
- Q411917 wikiPageWikiLink Q337554.
- Q411917 wikiPageWikiLink Q35869.
- Q411917 wikiPageWikiLink Q36496.
- Q411917 wikiPageWikiLink Q38933.
- Q411917 wikiPageWikiLink Q40878.
- Q411917 wikiPageWikiLink Q410546.
- Q411917 wikiPageWikiLink Q410959.
- Q411917 wikiPageWikiLink Q47273.
- Q411917 wikiPageWikiLink Q4862743.
- Q411917 wikiPageWikiLink Q507154.
- Q411917 wikiPageWikiLink Q5621038.
- Q411917 wikiPageWikiLink Q761862.
- Q411917 wikiPageWikiLink Q8343807.
- Q411917 wikiPageWikiLink Q84230.
- Q411917 wikiPageWikiLink Q86.
- Q411917 wikiPageWikiLink Q8614491.
- Q411917 wikiPageWikiLink Q8647962.
- Q411917 wikiPageWikiLink Q8808791.
- Q411917 wikiPageWikiLink Q8844484.
- Q411917 wikiPageWikiLink Q935781.
- Q411917 atcPrefix "A03".
- Q411917 atcSuffix "AB02".
- Q411917 casNumber "596".
- Q411917 drugName "Glycopyrronium".
- Q411917 drugbank "DB00986".
- Q411917 iupacName "3".
- Q411917 pubchem "11693".
- Q411917 pubchem "3494".
- Q411917 unii "V92SO9WP2I".
- Q411917 type ChemicalSubstance.
- Q411917 type Drug.
- Q411917 type ChemicalObject.
- Q411917 type Thing.
- Q411917 type Q8386.
- Q411917 comment "Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has no to few central effects. A synthetic quaternary amine, it is available in oral and intravenous (i.v.) forms. It was developed by Sosei and licensed to Novartis in 2005. The cation, which is the active moiety, is also known as glycopyrrolate.".
- Q411917 label "Glycopyrronium bromide".
- Q411917 depiction Glycopyrronium_bromide.svg.
- Q411917 name "Glycopyrronium".